Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03049033 : NMT for Parkinson's Disease
PhaseN/A
AgesMin: 45 Years Max: 85 Years
Eligibility
Inclusion Criteria:

- Age 45 to 85

- Diagnosis of Parkinson's Disease using the UK Brain Bank Criteria

- Fine motor impairments (if available, scores 2 and higher on the UPDRS motor
examination part III.23 and 24)

- Medication stable for at least 30 days.

Exclusion Criteria:

- Features suggestive of other causes of parkinsonism, including cerebrovascular disease
or history of major head trauma

- Inability to move fingers or hands

- Hoehn and Yahr stage 4 and higher

- Ferrous metal implants which may interfere with the MEG data acquisition and/or be an
MRI safety concern

- Dementia

- Participants engaged in other research studies involving music therapies

- Participants whose insurance does not cover Occupational Therapy costs or who have no
insurance.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03049033      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740